* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Clinical Approach & Management Of CHF
Remote ischemic conditioning wikipedia , lookup
Cardiothoracic surgery wikipedia , lookup
Coronary artery disease wikipedia , lookup
Electrocardiography wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Heart failure wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Cardiac surgery wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Jatene procedure wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Myocardial infarction wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
CLINICAL APPROACH & MANAGEMENT OF CHF DR SARIKA GUPTA (MD,PHD) ASST. PROFESSOR DEFINITION A clinical syndrome Occurs when The heart is unable to pump enough blood to the body to meet its needs The heart is unable to dispose of systemic or pulmonary return adequately Or a combination of the two PATHOPHYSIOLOGY Systemic oxygen transport = cardiac output X systemic oxygen content Cardiac output = heart rate X stroke volume The primary determinants of stroke volume: afterload (pressure work) preload (volume work) contractility (intrinsic myocardial function) PATHOPHYSIOLOGY The heart can be viewed as a pump with an output proportional to its filling volume and inversely proportional to the resistance against which it pumps PATHOPHYSIOLOGY As ventricular end-diastolic volume increases, a healthy heart increases cardiac output until a maximum is reached The increased stroke volume obtained in this manner is due to stretching of myocardial fibers Resulting in increased wall tension, elevating myocardial oxygen consumption Cardiac muscle with compromised intrinsic contractility requires a greater degree of dilatation to produce increased stroke volume & does not achieve the same maximal cardiac output as normal myocardium does PATHOPHYSIOLOGY Lesion causing increased preload (left-to-right shunt or valvular insufficiency) Cardiac chamber is already dilated Little room for further dilatation as a means of augmenting cardiac output Lesions that result in increased afterload to the ventricle (aortic or pulmonic stenosis, coarctation of the aorta) decreases cardiac performance PATHOPHYSIOLOGY Abnormalities in heart rate: compromise cardiac output Tachyarrhythmias shorten the diastolic time interval for ventricular filling. High-output failure: NO basic abnormality in myocardial function Cardiac output is greater than normal Alterations in the oxygen-carrying capacity of blood (anemia or hypoxemia) & increased oxygen demands (secondary to hyperventilation, hyperthyroidism, or hypermetabolism) PATHOPHYSIOLOGY ETIOLOGY FETAL Severe anemia (hemolysis, fetal-maternal transfusion, parvovirus B19–induced anemia, hypoplastic anemia) Supraventricular tachycardia Ventricular tachycardia Complete heart block Severe Ebstein anomaly or other severe right-sided lesions Myocarditis ETIOLOGY PREMATURE NEONATE Fluid overload Patent ductus arteriosus Ventricular septal defect Cor pulmonale (bronchopulmonary dysplasia) Hypertension Myocarditis Genetic cardiomyopathy ETIOLOGY FULL-TERM NEONATE Asphyxial cardiomyopathy Arteriovenous malformation (vein of Galen, hepatic) Left-sided obstructive lesions (coarctation of aorta, hypoplastic left heart syndrome) Large mixing cardiac defects (single ventricle, truncus arteriosus) Myocarditis Genetic cardiomyopathy ETIOLOGY INFANT-TODDLER Left-to-right cardiac shunts (ventricular septal defect) Hemangioma (arteriovenous malformation) Anomalous left coronary artery Genetic or metabolic cardiomyopathy Acute hypertension (hemolytic-uremic syndrome) Supraventricular tachycardia Kawasaki disease Myocarditis ETIOLOGY CHILD-ADOLESCENT Rheumatic fever Acute hypertension (glomerulonephritis) Myocarditis Thyrotoxicosis Hemochromatosis-hemosiderosis Cancer therapy (radiation, doxorubicin) Sickle cell anemia Endocarditis Cor pulmonale (ILD, cystic fibrosis) Genetic or metabolic cardiomyopathy CLINICAL FEATURES Depend on the degree of the child's cardiac reserve A critically ill infant or child who has exhausted the compensatory mechanisms- symptomatic at rest Other patients may be comfortable when quiet but are incapable of increasing cardiac output in response to even mild activity without experiencing significant symptoms CLINICAL FEATURES History: Poor feeding, poor weigh gain, tachypnea (worsening during feeding), cold sweat on the forehead- CHF in infants Shortness of breath, specially with activities, easy fatigability, puffy eyelids or swollen feet-older children CLINICAL FEATURES Examination: COMPENSATORY RESPONSE Tachycardia, gallop rhythm, weak & thready pulses Growth failure, perspiration, cold & wet skin Cardiomegaly PULMONARY VENOUS CONGESTION Tachypnea Dyspnea on exertion Orthopnea Wheezing & pulmonary crackles CLINICAL FEATURES Examination: SYSTEMIC VENOUS CONGESTION Hepatomegaly Puffy eyelids Distended neck veins Ankle edema Clinical assessment of jugular venous pressure in infants may be difficult because of the shortness of the neck & the difficulty of observing a relaxed state; palpation of an enlarged liver is a more reliable sign Edema may be generalized & involves the eyelids & sacrum & less often the legs and feet CLINICAL FEATURES INVESTIGATION X-RAY Study: INVESTIGATION X-RAY Study: INVESTIGATION ECG: not helpful ECHO: Standard technique for assessing ventricular function The most commonly used parameter in children is fractional shortening (impaired LV systolic function) Difference between end-systolic & end-diastolic diameter divided by end-diastolic diameter (N=28%42%) Ejection fraction (impaired LV systolic function) Enlargement of ventricular chambers Doppler tissue imaging (impaired LV systolic & diastolic function) INVESTIGATION Magnetic resonance angiography Cardiac catheterization-evaluation of biopsy specimens Decreased arterial oxygen levels; respiratory or metabolic acidosis Hyponatremia Serum B-type natriuretic peptide (BNP) Cardiac neurohormone released in response to increased ventricular wall tension Elevated in patients with heart failure due to systolic dysfunction (cardiomyopathy) Elevated in children with volume overload (left-toright shunts such as ventricular septal defect) MANAGEMENT PRINCIPAL: Elimination of the underlying causes Treatment of the precipitating or contributing causes (infection, anemia, arrhythmias, fever) Control of the heart failure state MANAGEMENT Control of the heart failure– GENERAL MEASURES Bed rest Humidified oxygen Adequate calories & fluid 1. Calorie dense food 2. Frequent small feeding 3. Nasogastric feeding 4. Salt restrictions Patients with pulmonary edema- positive pressure ventilation Daily weight measurement in hospitalized children MANAGEMENT Control of the heart failure state- Drug therapy Inotropic agents Diuretics Afterload reducing agents DIURETICS: interfere with reabsorption of water & sodium by the kidneys results in a reduction in circulating blood volume thereby reduces preload & control pulmonary & systemic venous congestive symptoms MANAGEMENT INOTROPIC AGENTS: Rapidly acting Inotropic agents Dopamine, dobutamine, isoproterenol, epinephrine & amrinone Additional vasodilator actions Used for critically ill infants with CHF, those with renal dysfunction & postoperative cardiac patients with CHF Digoxin MANAGEMENT AFTERLOAD REDUCING AGENTS: Arteriolar vasodilator Augments cardiac output by acting primarily on the arteriolar bed Reduction of afterload Hydralazine Venodilators Dilate systemic veins & redistribute blood from the pulmonary to the systemic circuits Decrease in pulmonary symptoms Nitriglycerine, isosorbide dinitrate MANAGEMENT AFTERLOAD REDUCING AGENTS: Mixed vasodilator Act on both arteriolar & venous beds ACE inhibitors, nitroprusside & prazosin ACEIs have additional beneficial effects on cardiac structure & function that may be independent of their effect on afterload MANAGEMENT AFTERLOAD REDUCING AGENTS: Afterload reducers: especially useful in children with heart failure secondary to cardiomyopathy & in patients with severe mitral or aortic insufficiency Effective in patients with heart failure caused by leftto-right shunts Not used in the presence of stenotic lesions of the left ventricular outflow tract because of concern over coronary perfusion MANAGEMENT β-ADRENERGIC BLOCKERS: β-Blockers are used for the chronic treatment of patients with heart failure who were symptomatic despite being treated with standard anticongestive drugs MANAGEMENT MANAGEMENT